Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Type 1 Diabetes Mellitus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Chicago, Chicago, Illinois, United States
Contact: Study coordinator (Piotr Witkowski, MD PhD) · pwitkowski@surgery.bs.uchicago.edu · 773 702 2447

Study leads

Piotr Witkowski, MD PhD
Principal Investigator
University of Chicago

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

Type 1 Diabetes Mellitus With Hypoglycemia

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Little Rock, United States

Type 1 Diabetes Extension Study

Type 1 Diabetes Mellitus · T1DM · T1D

Abroad (travel likely)Recruiting

San Francisco, United States · Stanford, United States

Swiss Diabetes Registry - SwissDiab Study

Diabetes Mellitus

Abroad (travel likely)Recruiting

Bern, Switzerland · Lausanne, Switzerland

Home-based Oral Glucose Tolerance Test for Type 1 Diabetes Screening

Type 1 Diabetes

Abroad (travel likely)Recruiting

New Haven, United States